UBS AM’s Artiva Biotherapeutics ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235 Buy
+33
New +$333 ﹤0.01% 4202

Other funds holding ARTV

UBS AM's ARTV Position: Q3 2026 in Review

UBS AM opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 33 shares worth $235. The stake represents ﹤0.01% of the portfolio and ranks #4202 among its holdings.

75 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

  • UBS AM held 33 shares of Artiva Biotherapeutics worth $235 as of Q3 2026.
  • Artiva Biotherapeutics was a new UBS AM position in Q3 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4202 holding.
  • 75 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.